306 related articles for article (PubMed ID: 30478168)
1. Multicenter Population Pharmacokinetic Study of Colistimethate Sodium and Colistin Dosed as in Normal Renal Function in Patients on Continuous Renal Replacement Therapy.
Leuppi-Taegtmeyer AB; Decosterd L; Osthoff M; Mueller NJ; Buclin T; Corti N
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478168
[TBL] [Abstract][Full Text] [Related]
2. Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.
Karaiskos I; Friberg LE; Pontikis K; Ioannidis K; Tsagkari V; Galani L; Kostakou E; Baziaka F; Paskalis C; Koutsoukou A; Giamarellou H
Antimicrob Agents Chemother; 2015 Dec; 59(12):7240-8. PubMed ID: 26369974
[TBL] [Abstract][Full Text] [Related]
3. Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.
Luque S; Escaño C; Sorli L; Li J; Campillo N; Horcajada JP; Salas E; Grau S
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559275
[TBL] [Abstract][Full Text] [Related]
4. Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration.
Karaiskos I; Friberg LE; Galani L; Ioannidis K; Katsouda E; Athanassa Z; Paskalis H; Giamarellou H
Int J Antimicrob Agents; 2016 Sep; 48(3):337-41. PubMed ID: 27474468
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and pharmacokinetics of colistimethate sodium and colistin in critically ill patients in an Indian hospital with high endemic rates of multidrug-resistant Gram-negative bacterial infections: A prospective observational study.
Moni M; Sudhir AS; Dipu TS; Mohamed Z; Prabhu BP; Edathadathil F; Balachandran S; Singh SK; Prasanna P; Menon VP; Patel T; Patel P; Kaye KS; Menon VP
Int J Infect Dis; 2020 Nov; 100():497-506. PubMed ID: 32781161
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.
Plachouras D; Karvanen M; Friberg LE; Papadomichelakis E; Antoniadou A; Tsangaris I; Karaiskos I; Poulakou G; Kontopidou F; Armaganidis A; Cars O; Giamarellou H
Antimicrob Agents Chemother; 2009 Aug; 53(8):3430-6. PubMed ID: 19433570
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic analysis of colistin in burn patients.
Lee J; Han S; Jeon S; Hong T; Song W; Woo H; Yim DS
Antimicrob Agents Chemother; 2013 May; 57(5):2141-6. PubMed ID: 23439640
[TBL] [Abstract][Full Text] [Related]
8. New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale.
Grégoire N; Mimoz O; Mégarbane B; Comets E; Chatelier D; Lasocki S; Gauzit R; Balayn D; Gobin P; Marchand S; Couet W
Antimicrob Agents Chemother; 2014 Dec; 58(12):7324-30. PubMed ID: 25267662
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection.
Karnik ND; Sridharan K; Jadhav SP; Kadam PP; Naidu RK; Namjoshi RD; Gupta V; Gore MS; Surase PV; Mehta PR; Gogtay JA; Thatte UM; Gogtay NJ
Eur J Clin Pharmacol; 2013 Jul; 69(7):1429-36. PubMed ID: 23508665
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of colistin methanesulfonate and formed colistin in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis.
Koomanachai P; Landersdorfer CB; Chen G; Lee HJ; Jitmuang A; Wasuwattakul S; Sritippayawan S; Li J; Nation RL; Thamlikitkul V
Antimicrob Agents Chemother; 2014; 58(1):440-6. PubMed ID: 24189256
[TBL] [Abstract][Full Text] [Related]
11. Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis.
Jacobs M; Grégoire N; Mégarbane B; Gobin P; Balayn D; Marchand S; Mimoz O; Couet W
Antimicrob Agents Chemother; 2016 Jan; 60(3):1788-93. PubMed ID: 26729492
[TBL] [Abstract][Full Text] [Related]
12. Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical.
Sorlí L; Luque S; Li J; Campillo N; Danés M; Montero M; Segura C; Grau S; Horcajada JP
J Infect; 2019 Sep; 79(3):253-261. PubMed ID: 31265867
[TBL] [Abstract][Full Text] [Related]
13. Colistin pharmacokinetics in intensive care unit patients on continuous venovenous haemodiafiltration: an observational study.
Markou N; Fousteri M; Markantonis SL; Zidianakis B; Hroni D; Boutzouka E; Baltopoulos G
J Antimicrob Chemother; 2012 Oct; 67(10):2459-62. PubMed ID: 22790220
[TBL] [Abstract][Full Text] [Related]
14. Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill.
Mohamed AF; Karaiskos I; Plachouras D; Karvanen M; Pontikis K; Jansson B; Papadomichelakis E; Antoniadou A; Giamarellou H; Armaganidis A; Cars O; Friberg LE
Antimicrob Agents Chemother; 2012 Aug; 56(8):4241-9. PubMed ID: 22615285
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
Philpott CD; Droege CA; Droege ME; Healy DP; Courter JD; Ernst NE; Harger NJ; Foertsch MJ; Winter JB; Carter KE; Van Fleet SL; Athota K; Mueller EW
Pharmacotherapy; 2019 Nov; 39(11):1066-1076. PubMed ID: 31549737
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of Colistin Following a Single Dose of Intravenous Colistimethate Sodium in Critically Ill Neonates.
Nakwan N; Usaha S; Chokephaibulkit K; Villani P; Regazzi M; Imberti R
Pediatr Infect Dis J; 2016 Nov; 35(11):1211-1214. PubMed ID: 27276179
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.
Garonzik SM; Li J; Thamlikitkul V; Paterson DL; Shoham S; Jacob J; Silveira FP; Forrest A; Nation RL
Antimicrob Agents Chemother; 2011 Jul; 55(7):3284-94. PubMed ID: 21555763
[TBL] [Abstract][Full Text] [Related]
18. Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study.
Broeker A; Wicha SG; Dorn C; Kratzer A; Schleibinger M; Kees F; Heininger A; Kees MG; Häberle H
Crit Care; 2018 Dec; 22(1):341. PubMed ID: 30558639
[TBL] [Abstract][Full Text] [Related]
19. Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?
Sorli L; Luque S; Li J; Rodríguez E; Campillo N; Fernandez X; Soldado J; Domingo I; Montero M; Grau S; Horcajada JP
Molecules; 2019 Feb; 24(3):. PubMed ID: 30717123
[TBL] [Abstract][Full Text] [Related]
20. A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration.
Sime FB; Lassig-Smith M; Starr T; Stuart J; Pandey S; Parker SL; Wallis SC; Lipman J; Roberts JA
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]